These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 187795)

  • 21. Immunopathology of natural and experimental lymphomas induced by wild mouse leukemia virus.
    Bryant ML; Scott JL; Pal BK; Estes JD; Gardner MB
    Am J Pathol; 1981 Sep; 104(3):272-82. PubMed ID: 6271013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. II. Antibody response to viral envelope antigens.
    Vlug A; Melief CJ; de Bruyne C; Schoenmakers H; Molenaar JL
    J Natl Cancer Inst; 1980 May; 64(5):1191-8. PubMed ID: 6245302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the allospecific and viral-specific immune responses to irradiated versus formaldehyde-fixed allogeneic Moloney lymphoma cells in CBA mice.
    Lamon EW; Gatti RA; Kiessling R; Fenyö EM
    Cancer Res; 1975 Apr; 35(4):962-9. PubMed ID: 1090367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
    Lee JC; Ihle JN; Huebner R
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in humoral immune response to bovine leukaemia virus antigens in cattle with lymphoma.
    Heeney JL; Valli VE; Montesanti J
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():659-66. PubMed ID: 2832529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus.
    Cerny J; Waner EB
    J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of H-2 complex on susceptibility to infection by murine leukemia virus.
    Tucker HSt ; Weens J; Tsichlis P; Schwartz RS; Khiroya R; Donnelly J
    J Immunol; 1977 Apr; 118(4):1239-43. PubMed ID: 191531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective thymic localization of murine leukemia virus-related antigens in C57BL-Ka mice after inoculation with radiation virus.
    Declève A; Sato C; Lieberman M; Kaplan HS
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3124-8. PubMed ID: 4370358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type C virus expression in lymphoma-paralysis-prone wild mice.
    Gardner MB; Klement V; Rongey RR; McConahey P; Estes JD; Huebner RJ
    J Natl Cancer Inst; 1976 Sep; 57(3):585-90. PubMed ID: 185401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of host immune status during progressive growth and after excision of DNA virus (simian virus 40) tumors in hamsters: comparison of tumor-specific and tumor-unrelated parameters of immune responsiveness.
    Houston KJ; Blasecki JW
    J Natl Cancer Inst; 1979 Sep; 63(3):665-73. PubMed ID: 224234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopathogenicity and oncogenicity of murine leukemia virus. III. Quantitation of spontaneous virus expression.
    Croker BP; McConahey PJ; Murphy ED; Dixon FJ
    J Natl Cancer Inst; 1977 Jul; 59(1):199-205. PubMed ID: 195068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction, via immunization with a monoclonal antiidiotypic antibody, of viral envelope specific Ab3 antisera that neutralize retrovirus infectivity.
    Rich RF; Mayes BE; Abate MI; Green WR
    Viral Immunol; 1993; 6(3):193-206. PubMed ID: 7507328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological studies of tumor antigens in chemical- and virus-induced thymic lymphomas.
    Doell RG; Mathieson BJ
    Cancer Res; 1971 Sep; 31(9):1285-9. PubMed ID: 4329884
    [No Abstract]   [Full Text] [Related]  

  • 36. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
    Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines.
    Chesebro B; Wehrly K; Chesebro K; Portis J
    J Immunol; 1976 Oct; 117(4):1267-74. PubMed ID: 185295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary virus-induced lymphomas evade T cell immunity by failure to express viral antigens.
    Vasmel WL; Sijts EJ; Leupers CJ; Matthews EA; Melief CJ
    J Exp Med; 1989 Apr; 169(4):1233-54. PubMed ID: 2538550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunofluorescent antibody studies of a murine leukemia virus: comparison of human, bovine and murine systems.
    Brown ER; Buinauskas P; Schwartz SO
    Experientia; 1966 Oct; 22(10):687-9. PubMed ID: 4291375
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
    Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
    J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.